Anna Nijdam - 21 May 2026 Form 4 Insider Report for Pharvaris N.V. (PHVS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 May 2026, 17:45:32 UTC
Prior SEC filing
14 Apr 2026
Next SEC filing
08 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Marnus Nel, Attorney-in-Fact for Anna Nijdam

Key filing fact

Anna Nijdam filed Form 4 for Pharvaris N.V. (PHVS) on 26 May 2026.

Key facts

  • This page summarizes Anna Nijdam's Form 4 filing for Pharvaris N.V. (PHVS).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 26 May 2026, 17:45.

Change

  • Previous filing in this sequence was filed on 14 Apr 2026.
  • Current net transaction value: -$225,055.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001973872 Primary reporting owner

Nijdam Anna

Relationship
Principal Accounting Officer
Address
1 CRANBERRY HILL SUITE 400, LEXINGTON
Signature
/s/ Marnus Nel, Attorney-in-Fact for Anna Nijdam
Signature date
26 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PHVS transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,829
Change %
+3.7%
Price
$20.00*
Shares after
50,774
Date
21 May 2026
Ownership
Direct
Footnotes
F1
PHVS transaction

Common Stock

Sale

Transaction value
$55,971
Shares
-1,829
Change %
-3.6%
Price
$30.60
Shares after
48,945
Date
21 May 2026
Ownership
Direct
Footnotes
F2
PHVS transaction

Common Stock

Options Exercise

Transaction value
Shares
+5,501
Change %
+11%
Price
$20.00*
Shares after
54,446
Date
22 May 2026
Ownership
Direct
PHVS transaction

Common Stock

Sale

Transaction value
$169,084
Shares
-5,501
Change %
-10%
Price
$30.74
Shares after
48,945
Date
22 May 2026
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PHVS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-1,829
Change %
-6.1%
Price
$0.000000*
Shares after
28,171
Date
21 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,000
Exercise price
$20.00
Footnotes
F4
PHVS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-5,501
Change %
-20%
Price
$0.000000*
Shares after
22,670
Date
22 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,000
Exercise price
$20.00
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On April 14, 2026, the reporting person reported an RSU vesting transaction in which 5 additional shares were inadvertently reported as withheld for tax obligations, resulting in an understatement of total beneficial ownership. Following correction of the tax withholding share amount, total beneficial ownership as of April 11, 2026 should have been 48,945 shares rather than 48,940 shares reported previously.

Footnote F2

The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $30.60 to $30.61. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Footnote F3

The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $30.60 to $31.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Footnote F4

25% of the option vested on February 5, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .